Gloria Petersen

Professor of Epidemiology and Principal Investigator for the Pancreatic Cancer SPORE, Mayo Clinic. Opinions tweeted are my own.

[Gloria Petersen @GMPetersen1]

@NCIDirector @theNCI Thank you for your outstanding service to cancer patients and the research community. Best wishes to you.

[Gloria Petersen @GMPetersen1]

@HCCvPDAC Howard, Sincerest congratulations to you! What a huge opportunity to make difference and create a dedicated new PC focus at HFH! Look forward to hearing more!

[Gloria Petersen @GMPetersen1]

Inspiring patient story from Mayo Clinic; mentions PanCAN. Both are great organizations!
https://t.co/rMmXy1s5mW

[Gloria Petersen @GMPetersen1]

It was such a privilege to be part of faculty and work with trainees, all focused on solving pancreatic cancer! #CSHLPancreasCancer

[Gloria Petersen @GMPetersen1]

@Aiims1742 @letswinpc @alisonpklein @SU2Cscience @KFRFNYC Great session! I enjoyed hearing from the other experts!

[Gloria Petersen @GMPetersen1]

@letswinpc People who have new onset diabetes will have regular research blood samples taken that can be tested in the future with lab tests

[Gloria Petersen @GMPetersen1]

@letswinpc There is a national effort, funded by the National Cancer Institute and PanCAN to study new onset diabetic patients

[Gloria Petersen @GMPetersen1]

@letswinpc Researchers are working on blood tests to help discriminate new onset diabetes due to having pancreatic cancer

[Gloria Petersen @GMPetersen1]

@letswinpc Our challenge is picking out the 1% from the 99% of new onset diabetics

[Gloria Petersen @GMPetersen1]

@letswinpc While 99% of people who develop diabetes truly have type 2 diabetes, around 1% develop diabetes because the pancreatic cancer causes it.

[Gloria Petersen @GMPetersen1]

#PancChat

There will soon open a concerted effort among many research
centers to collect blood samples annually from patients who have been found by
genetic testing to carry a PC predisposition mutation or who have a strong family history of pancreatic cancer.

[Gloria Petersen @GMPetersen1]

@drallysonocean @lustgartenfdn @HopkinsKimmel @PennCancer @SU2C The key to diagnosing pancreatic cancer will be a good understanding of the biology of the tumor and of the epidemiologic patterns of early signs of the cancer.

[Gloria Petersen @GMPetersen1]

@drallysonocean @lustgartenfdn @HopkinsKimmel @PennCancer @SU2C The 2nd high risk group are persons over age 50 who have had a recent diagnosis of diabetes, and experiencing weight loss. Some researchers use the ENDPAC model (ENDPAC: Enriching New-Onset Diabetes for Pancreatic Cancer) developed by Mayo Clinic docs (Gastroenterology.2018 Sep)

[Gloria Petersen @GMPetersen1]

@drallysonocean @lustgartenfdn @HopkinsKimmel @PennCancer @SU2C The blood samples from these individuals will be tested for biomarkers that may indicate the presence of an early cancer.

[Gloria Petersen @GMPetersen1]

@drallysonocean @lustgartenfdn @HopkinsKimmel @PennCancer @SU2C There will soon open a concerted effort among many research
centers to collect blood samples annually from patients who have been found by
genetic testing to carry a mutation in a gene that is associated with
pancreatic cancer susceptibility, or who have a strong family history.

[Gloria Petersen @GMPetersen1]

@letswinpc The second high risk group are persons over age 50 who have had a recent diagnosis of diabetes, and experiencing weight loss. We study the ENDPAC model (ENDPAC: Enriching New-Onset Diabetes for Pancreatic Cancer) developed by Mayo Clinic docs (Gastroenterology. Sep 2018)

[Gloria Petersen @GMPetersen1]

@letswinpc There are two high risk groups that researchers are targeting for study: the first group are persons with strong genetic or familial predisposition

[Gloria Petersen @GMPetersen1]

@letswinpc We researchers are developing early detection tests that will be valid and
reliable when researchers have the study samples from clearly defined high risk
groups of people.

[Gloria Petersen @GMPetersen1]

@letswinpc The key to diagnosing pancreatic cancer will be a good understanding of the biology of the tumor and of the epidemiologic patterns of early signs of the cancer.

[Gloria Petersen @GMPetersen1]

@NirajGusani @letswinpc @PanCAN @lustgartenfdn @drallysonocean @ShaalanBeg @SU2C @PurpleOurWorld As a result of failure to diagnose pancreatic cancer early, the therapies are limited (and the prognosis is less encouraging)